JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
CALL
AstraZeneca
AZN
$244B
| $2.49M | ﹤0.01% |
25,000
| – | – |
|
3077
PUT
Goodyear
GT
$1.74B
| $2.49M | ﹤0.01% |
160,000
| – | – |
|
3078
Pricesmart
PSMT
$5.49B
| $2.48M | ﹤0.01% |
34,921
-13,751
| -28% | -$988K |
|
|
VAL
3079
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $2.48M | ﹤0.01% |
377,362
+374,165
| +11,704% | +$1.82M |
|
3080
Werner Enterprises
WERN
$2.27B
| $2.48M | ﹤0.01% |
68,037
-623
| -0.9% | -$22.8K |
|
3081
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$306M
| $2.47M | ﹤0.01% |
93,226
-22,090
| -19% | -$564K |
|
|
CWBC
3082
Community West Bancshares
CWBC
$701M
| $2.47M | ﹤0.01% |
114,077
+870
| +0.8% | +$18.2K |
|
|
DAO
3083
Youdao
DAO
$2.23B
| $2.46M | ﹤0.01% |
+175,000
| New | +$2.46M |
|
3084
CALL
General Mills
GIS
$20.4B
| $2.46M | ﹤0.01% |
46,000
+5,000
| +12% | +$263K |
|
3085
Adtran
ADTN
$665M
| $2.46M | ﹤0.01% |
248,748
+14,823
| +6% | +$141K |
|
3086
CALL
Southern Company
SO
$106B
| $2.46M | ﹤0.01% |
38,600
-40,000
| -51% | -$2.48M |
|
3087
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $2.46M | ﹤0.01% |
65,402
-592
| -0.9% | -$21.3K |
|
3088
CALL
Galicia Financial Group
GGAL
$7.1B
| $2.46M | ﹤0.01% |
151,400
-418,600
| -73% | -$5.53M |
|
|
NEWR
3089
DELISTED
New Relic, Inc.
NEWR
| $2.46M | ﹤0.01% |
37,380
-217,031
| -85% | -$14.1M |
|
3090
PUT
Aflac
AFL
$60.5B
| $2.46M | ﹤0.01% |
46,400
| – | – |
|
3091
PUT
Digital Realty Trust
DLR
$72.9B
| $2.46M | ﹤0.01% |
20,500
-5,900
| -22% | -$726K |
|
|
JCAP
3092
DELISTED
Jernigan Capital, Inc.
JCAP
| $2.45M | ﹤0.01% |
128,140
-17,566
| -12% | -$323K |
|
3093
Hyatt Hotels
H
$16.8B
| $2.45M | ﹤0.01% |
27,275
-418,839
| -94% | -$32.7M |
|
3094
Graham Corp
GHM
$1.33B
| $2.44M | ﹤0.01% |
111,690
-56,195
| -33% | -$1.21M |
|
3095
Archrock
AROC
$5.84B
| $2.44M | ﹤0.01% |
242,579
+48,930
| +25% | +$456K |
|
|
CLVS
3096
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.43M | ﹤0.01% |
233,300
+213,900
| +1,103% | +$1.56M |
|
|
BEST
3097
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $2.43M | ﹤0.01% |
21,880
+21,876
| +546,900% | +$2.4M |
|
3098
CALL
TripAdvisor
TRIP
$1.26B
| $2.43M | ﹤0.01% |
80,000
| – | – |
|
|
FPRX
3099
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.43M | ﹤0.01% |
529,188
+123,507
| +30% | +$489K |
|
3100
Cohu
COHU
$2.76B
| $2.42M | ﹤0.01% |
106,009
+25,342
| +31% | +$455K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.